Your browser doesn't support javascript.
loading
General practitioners' perceptions on opportunistic single-time point screening for atrial fibrillation: A European quantitative survey.
Vermunicht, Paulien; Grecu, Mihaela; Deharo, Jean-Claude; Buckley, Claire M; Palà, Elena; Mairesse, Georges H; Farkowski, Michal M; Bergonti, Marco; Pürerfellner, Helmut; Hanson, Coral L; Neubeck, Lis; Freedman, Ben; Witt, Henning; Hills, Mellanie T; Lund, Jenny; Giskes, Katrina; Engler, Daniel; Schnabel, Renate B; Heidbuchel, Hein; Desteghe, Lien.
Afiliación
  • Vermunicht P; Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium.
  • Grecu M; Research Group Cardiovascular Diseases, University of Antwerp, Antwerp, Belgium.
  • Deharo JC; Electrophysiology Department, Cardiovascular Diseases Institute, Iasi, Romania.
  • Buckley CM; Assistance Publique - Hôpitaux de Marseille and Aix Marseille Université, C2VN, Marseille, France.
  • Palà E; School of Public Health, University College Cork, Cork, Ireland.
  • Mairesse GH; Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR) - Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Farkowski MM; Cliniques du Sud Luxembourg, Arlon, Belgium.
  • Bergonti M; II Department of Heart Arrhythmia, National Institute of Cardiology, Warszawa, Poland.
  • Pürerfellner H; Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium.
  • Hanson CL; Research Group Cardiovascular Diseases, University of Antwerp, Antwerp, Belgium.
  • Neubeck L; Department of Cardiology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
  • Freedman B; School of Health and Social Care, Edinburgh Napier University, Edinburgh, United Kingdom.
  • Witt H; School of Health and Social Care, Edinburgh Napier University, Edinburgh, United Kingdom.
  • Hills MT; Heart Research Institute, The University of Sydney, Sydney, NSW, Australia.
  • Lund J; Charles Perkins Centre and Concord Hospital Cardiology, The University of Sydney, Sydney, NSW, Australia.
  • Giskes K; Pfizer Pharma GmbH, Berlin, Germany.
  • Engler D; StopAfib.org, Dallas, TX, United States.
  • Schnabel RB; Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Heidbuchel H; Heart Research Institute, The University of Sydney, Sydney, NSW, Australia.
  • Desteghe L; Department of General Practice, School of Medicine, University of Notre Dame, Sydney, NSW, Australia.
Front Cardiovasc Med ; 10: 1112561, 2023.
Article en En | MEDLINE | ID: mdl-36873407
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Screening_studies Idioma: En Revista: Front Cardiovasc Med Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Screening_studies Idioma: En Revista: Front Cardiovasc Med Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza